Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Noting that multiple sclerosis now affects more people between 50 and 60 than any other age group, researchers have shown how machine-learning gait analysis can help personalize therapy regimens.
Academic researchers in the U.K. have completed a systematic review of 62 representative studies on the use of AI for COVID-19 diagnostics and prognostics on X-rays and CT scans. Their findings may strike some as a setback.
Researchers have demonstrated that deep learning models can help neurologists interpret epileptic episodes during and between seizures from relatively few scalp electroencephalography (EEG) readings.
Researchers have developed an AI-based system that can direct the administering of iron and other red-blood-cell stimulators nearly as well as experienced physicians.
North America has bragging rights to the five best hospitals in the world, although institutions specifically in the United States make up only nine of the top 25.
More than 206,000 consumers enrolled in a healthcare plan during the Covid-19 special enrollment period (SEP), according to new data reported by Health Affairs.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
